Skip to main content
Anatomical Therapeutic Chemical • L04AC19 • satralizumab
L04AC02
basiliximab
Indicated for:
prevention of transplant rejection
L04AC03
anakinra
Indicated for:
autoimmune inflammatory diseases
L04AC05
ustekinumab
Indicated for:
autoimmune inflammatory diseases
L04AC07
tocilizumab
Indicated for:
autoimmune inflammatory diseases
L04AC08
canakinumab
Indicated for:
autoimmune inflammatory diseases
L04AC10
secukinumab
Indicated for:
autoimmune inflammatory diseases
L04AC11
siltuximab
Indicated for:
cancer
L04AC13
ixekizumab
Indicated for:
autoimmune inflammatory diseases
L04AC16
guselkumab
Indicated for:
autoimmune inflammatory diseases
L04AC17
tildrakizumab
Indicated for:
psoriasis
L04AC18
risankizumab
Indicated for:
autoimmune inflammatory diseases
L04AC19
satralizumab
Indicated for:
neuromyelitis optica spectrum disorder
L04AC21
bimekizumab
Indicated for:
psoriasis
L04AC22
spesolimab
Indicated for:
generalized pustular psoriasis
L04AC24
mirikizumab
Indicated for:
ulcerative colitis